Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies
Detection Principle
ImmunoAssay-Antibody
Target
IgM, IgG, IgA and total Ab
Testing Method
ELISA kits
Testing Method - Additional Info
The NovaLisa SARS?CoV?2 IgG, IgA, IgM test (NovaTec) and the Platelia SARS?CoV?2 Total Ab test (Bio?Rad)
Reported Performance
sensitivity: 94.9% (NovaLisa, IgG), 89.7% (NovaLisa, IgA), 48.7% (NovaLisa, IgM), 94.9% (Platelia, total Ab); specificity: 96.2% (NovaLisa, IgG), 98.7% (NovaLisa, IgA), 98.7% (NovaLisa, IgM), 97.4% (Platelia, total Ab)
Sample Size
208 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements